Investigation and management of papillary thyroid microcarcinoma – a Scottish regional case series and literature review

1. Lloyd, RV, Osamura, RY, Klöppel, GR. WHO classification of tumours: pathology and genetics of tumours of endocrine organs. 4th ed. Lyon: IARC, 2017.
Google Scholar2. Roti, E, Degli Uberti, EC, Bondanelli, M, et al. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 2008; 159: 659–673.
Google Scholar | Crossref | Medline | ISI3. Perros, P, Colley, S, Boelaert, K, et al. British thyroid association guidelines for the management of thyroid cancer. Clin Endocrinol 2014; 81: 1–122.
Google Scholar | Crossref | Medline | ISI4. Kawano, S, Miyauchi, A, Ito, Y. Routine chest computed tomography at presentation does not identify distant metastasis in cT1aN0 papillary thyroid carcinoma. Thyroid 2020; 30: 1620–1624.
Google Scholar | Crossref | Medline5. Haugen, BR, Alexander, EK, Bible, KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26: 1–133.
Google Scholar | Crossref | Medline | ISI6. Mitchell, AL, Gandhi, A, Scott-Coombes, D, et al. Management of thyroid cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol 2016; 130: S150–S160.
Google Scholar | Crossref | Medline7. Agha, R, Abdall-Razak, A, Crossley, E, et al. STROCSS 2019 guideline: strengthening the reporting of cohort studies in surgery. Int J Surg 2019; 72: 156–165.
Google Scholar | Crossref | Medline8. Pacini, F. Thyroid microcarcinoma. Best Pract Res Clin Endocrinol Metab 2012; 26: 381–389.
Google Scholar | Crossref | Medline9. Bradley, NL, Wiseman, SM. Papillary thyroid microcarcinoma: the significance of high risk features. BMC Cancer 2017; 17: Article 142.
Google Scholar | Crossref | Medline10. Mehanna, H, Al-Maqbili, T, Carter, B, et al. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab 2014; 99: 2834–2843.
Google Scholar | Crossref | Medline11. Harari, A, Li, N, Yeh, MW. Racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer. J Clin Endocrinol Metab 2014; 99: 133–141.
Google Scholar | Crossref | Medline | ISI12. Walsh, D, Bendel, N, Jones, R, et al. It’s not “just deprivation”: why do equally deprived UK cities experience different health outcomes? Public Health 2010; 124: 487–495.
Google Scholar | Crossref | Medline13. Siddiqui, S, White, MG, Antic, T, et al. Clinical and pathologic predictors of lymph node metastasis and recurrence in papillary thyroid microcarcinoma. Thyroid 2016; 26: 807–815.
Google Scholar | Crossref | Medline14. Choi, JS, Kim, J, Kwak, JY, et al. Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. Am J Roentgenol 2009; 193: 871–878.
Google Scholar | Crossref | Medline15. Lee, DH, Kim, YK, Yu, HW, et al. Computed tomography for detecting cervical lymph node metastasis in patients who have papillary thyroid microcarcinoma with tumor characteristics appropriate for active surveillance. Thyroid 2019; 29: 1653–1659.
Google Scholar | Crossref | Medline16. Leswick, DA, Webster, ST, Wilcox, BA, et al. Radiation cost of helical high-resolution chest CT. AJR Am J Roentgenol 2005; 184: 742–745.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif